News
Higher potency of fentanyl affects addiction treatment, screening
In many if not most cases, patients become addicted to fentanyl unknowingly, said Dr. Edwin Salsitz.
In many if not most cases, patients become addicted to fentanyl unknowingly, said Dr. Edwin Salsitz.
For some patients it could mean missing the chance for long-term survival or even cure.
Several companies have already withdrawn their respective PARP inhibitors for heavily pretreated patients with ovarian cancer.
Late-breaking results from ACR 2022 on bimekizumab in axial spondyloarthritis, along with studies on the use of combination therapy and the...
Doctor says real-world toxicity experience has been worse than clinical trial data.
Just do what you’re already doing, but with a little more effort, suggests a new study.
The clinical data the company submitted was deemed insufficient for approval.
Less than 6% of high-risk smokers get the recommended annual lung cancer screening.
The anti-PD-L1 inhibitor continues to be approved for lung and liver cancers and melanoma.
The application for Rebyota received priority review and had orphan drug and breakthrough therapy designation.